469 related articles for article (PubMed ID: 22128336)
1. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.
Hinson SR; Romero MF; Popescu BF; Lucchinetti CF; Fryer JP; Wolburg H; Fallier-Becker P; Noell S; Lennon VA
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1245-50. PubMed ID: 22128336
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Rossi A; Ratelade J; Papadopoulos MC; Bennett JL; Verkman AS
Glia; 2012 Dec; 60(12):2027-39. PubMed ID: 22987455
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Iorio R; Fryer JP; Hinson SR; Fallier-Becker P; Wolburg H; Pittock SJ; Lennon VA
J Autoimmun; 2013 Feb; 40():21-7. PubMed ID: 22906356
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
6. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4 by the Small Molecule Blocker Melanthioidine.
Xu H; Gong Y; Jiao Y; Guo J; Zhao L; Yang J; Tong H; Sun M; Li M
Curr Pharm Des; 2023; 29(10):793-802. PubMed ID: 36998134
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.
Tradtrantip L; Zhang H; Anderson MO; Saadoun S; Phuan PW; Papadopoulos MC; Bennett JL; Verkman AS
FASEB J; 2012 May; 26(5):2197-208. PubMed ID: 22319008
[TBL] [Abstract][Full Text] [Related]
10. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
Crane JM; Lam C; Rossi A; Gupta T; Bennett JL; Verkman AS
J Biol Chem; 2011 May; 286(18):16516-24. PubMed ID: 21454592
[TBL] [Abstract][Full Text] [Related]
11. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
[TBL] [Abstract][Full Text] [Related]
12. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
[TBL] [Abstract][Full Text] [Related]
13. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.
Verkman AS; Phuan PW; Asavapanumas N; Tradtrantip L
Brain Pathol; 2013 Nov; 23(6):684-95. PubMed ID: 24118484
[TBL] [Abstract][Full Text] [Related]
14. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.
Phuan PW; Ratelade J; Rossi A; Tradtrantip L; Verkman AS
J Biol Chem; 2012 Apr; 287(17):13829-39. PubMed ID: 22393049
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.
Abe Y; Yasui M
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454180
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
[TBL] [Abstract][Full Text] [Related]
17. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.
Hinson SR; Clift IC; Luo N; Kryzer TJ; Lennon VA
Proc Natl Acad Sci U S A; 2017 May; 114(21):5491-5496. PubMed ID: 28461494
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Ratelade J; Zhang H; Saadoun S; Bennett JL; Papadopoulos MC; Verkman AS
Acta Neuropathol; 2012 Jun; 123(6):861-72. PubMed ID: 22526022
[TBL] [Abstract][Full Text] [Related]
20. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
